GOLDMAN SACHS GROUP INC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q2 2024$4,966,810
-53.8%
255,363
-10.8%
0.00%
-50.0%
Q1 2024$10,739,071
-48.5%
286,146
-23.3%
0.00%
-50.0%
Q4 2023$20,865,974
+36.3%
372,873
+0.5%
0.00%
+33.3%
Q3 2023$15,306,143
-59.0%
371,058
-44.5%
0.00%
-62.5%
Q2 2023$37,330,660
+73.8%
668,529
+73.6%
0.01%
+60.0%
Q1 2023$21,484,561
-56.5%
385,097
-71.6%
0.01%
-58.3%
Q4 2022$49,423,317
+336433.5%
1,356,293
+163.0%
0.01%
+200.0%
Q3 2022$14,686
-49.4%
515,686
-19.6%
0.00%
-42.9%
Q2 2022$29,024
-99.9%
641,418
-6.5%
0.01%
-36.4%
Q1 2022$52,204,000
+75.0%
686,270
+242.7%
0.01%
+83.3%
Q4 2021$29,833,000
-6.4%
200,273
-8.5%
0.01%
-14.3%
Q3 2021$31,862,000
-69.7%
218,862
-59.2%
0.01%
-70.8%
Q2 2021$105,054,000
+12.5%
536,481
+4.0%
0.02%
+4.3%
Q1 2021$93,405,000
+65.5%
516,045
+29.5%
0.02%
+53.3%
Q4 2020$56,446,000
+12.6%
398,626
-0.8%
0.02%
+7.1%
Q3 2020$50,126,000
+56.1%
402,034
+11.8%
0.01%
+40.0%
Q2 2020$32,118,000
+184.5%
359,623
+98.5%
0.01%
+150.0%
Q1 2020$11,289,000
+49.0%
181,154
+82.3%
0.00%
+100.0%
Q4 2019$7,576,000
+5.8%
99,356
-30.1%
0.00%0.0%
Q3 2019$7,164,000142,1460.00%
Other shareholders
10X GENOMICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Venrock Management VI, LLC 2,106,757$117,894,122100.00%
Blue Water Life Science Advisors, LP 194,500$10,884,2209.53%
Sands Capital Ventures, LLC 481,770$26,959,8497.50%
Meritech Capital Associates V L.L.C. 494,236$27,657,4476.73%
Decheng Capital LLC 359,554$20,120,6425.62%
Iron Triangle Partners LP 479,374$26,825,7693.47%
Brown Capital Management 3,527,297$197,387,5402.96%
Freshford Capital Management, LLC 305,798$17,112,4562.78%
SVB WEALTH LLC 1,446,552$80,949,0661.97%
Capital Impact Advisors, LLC 23,594$1,320,3201.74%
View complete list of 10X GENOMICS INC shareholders